tree shake, page-11

You tried this scare tactic before when we jumped to 50c and are trying it again now at $1. I'm basically certain now you'll come in again at $1.50.

I'll basically repeat the same things I said to you then - your table is wrong on so many levels.

Lets obviously start with AGH. Firstly, the last quarterly revenue wasn't $135k, that was the cash receipts. Another reason you prove you dont understand how multiples work is you have different revenue timeframes for each stock then present them all as the same. You have basically presented it in a way that you want to portray the stocks.

Also told you back then that comparing hemp companies like EXL/EOFt o CAN/AGH is futile as their business models are entirely different.

And that's not even getting to the main point where trying to assess/value medicinal cannabis companies on a revenue multiple (in Australia) is completely asinine. Why do you think CAN is the best performer with one of the worst revenues?